Riskpilot← Back to searchSign inGet full accessWiksättraVård AB
ABActiveOrg 5591689616Krukmakargatan 51 Lgh 1001Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
SEK 247K
+21% vs 2024
EBITDA margin
40.9%
+1994% vs 2024
Equity ratio
80.0%
Financial strength
Net profit 2025
SEK 82K
+1442% vs 2024
| Revenue | SEK 247K | +21% |
| EBITDA | SEK 101K | +1994% |
| Net profit | SEK 82K | +1442% |
| Total assets | SEK 303K | +38% |
| Equity | SEK 243K | +15% |
| Employees | 1 | — |
Legal name
WiksättraVård AB
Org number
5591689616
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
24 augusti 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Utredning och medicinsk behandling av psykiatriska och neuropsykiatriska tillstånd. Arbete som hyrläkare och konsult över hela Sverige. Handledning och utbildning inom psykiatri och neuropsykiatri. Arbete inom beroendevård på mottagning, inom slutenvård och som tillsynsläkare på behandlingshem för missbrukare.
Address
Krukmakargatan 51 Lgh 1001
Email
kurre@kurwik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 760 | 992 | 426 | 203 | 247 |
| Staff expenses | — | −779 | −203 | −127 | −0 |
| EBITDA | 147 | 136 | 111 | 5 | 101 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 147 | 136 | 111 | 5 | 101 |
| Net financials | — | 0 | 1 | 2 | 2 |
| Profit before tax | 147 | 136 | 112 | 7 | 103 |
| Tax | −32 | −28 | −22 | −1 | −21 |
| Net profit | 115 | 108 | 90 | 5 | 82 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 367 | 507 | 284 | 220 | 303 |
| Equity | 238 | 345 | 255 | 211 | 243 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 130 | 161 | 28 | 9 | 60 |
| Total debt | 130 | 161 | 28 | 9 | 60 |
EBITDA margin
40.9%
This company
15.8%
Market median
+159% vs market
20212025
Equity ratio
80.0%
This company
38.2%
Market median
+109% vs market
20212025
Return on equity
33.8%
This company
18.4%
Market median
+84% vs market
20212025
Net profit margin
33.2%
This company
8.1%
Market median
+310% vs market
20212025
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20212025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-10-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of WiksättraVård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ruth Ann-Charlotte Wiklund | Board of Directors | 0 companies |
| Kurt Henning Wiklund | Deputy Board Member | 0 companies |